Prof. Wenhan Lin | Natural Product chemistry | Best Researcher Award

Prof. Wenhan Lin | Natural Product chemistry | Best Researcher Award

Professor at Ningbo Institute of Marine Medicine, Peking University | China

Professional Profile

Scopus

🎓 Education and Academic Journey

Prof. Dr. Wenhan Lin has built an illustrious academic career in medicinal chemistry. He completed his undergraduate studies in Chemistry at the Department of Chemistry, Zhijiang Normal University (1978–1982). His graduate journey led him to the Shanghai Institute of Materia Medica, Chinese Academy of Sciences (1985–1989), where he earned his Master’s and Ph.D. degrees.
He further enhanced his expertise during a postdoctoral fellowship at the School of Pharmaceutical Sciences, Peking University (1990–1992). Recognized for his academic excellence, he joined the university as an Associate Professor of Medicinal Chemistry (1992–1996) and has been serving as a Professor in the State Key Laboratory of Natural and Biomimetic Drugs since 1996.

🌍 International Experience

Dr. Lin’s career has been enriched by various international scholarly visits. He worked as a visiting scholar at the Federal University of Rio de Janeiro, Brazil (1993–1994), the Faculty of Pharmaceutical Sciences, Toho University, Japan (1995–1996), and the University of Düsseldorf, Germany (1999–2000) under a prestigious DAAD Special Program Award.

🔬 Research Focus

Prof. Lin’s research primarily explores bioactive metabolites derived from marine organisms such as sponges, corals, and marine mangrove plants. His work also delves into the microorganisms associated with these ecosystems, aiming to uncover novel natural products with therapeutic potential.
His investigations include:

Isolation and structural elucidation of novel natural compounds.

Bioassay studies to evaluate the bioactivity of these compounds.

Structural modification of bioactive molecules for new drug development.

Studying the interactions between drugs and target proteins.

Publications Top Noted📝

Praelolide alleviates collagen-induced arthritis through increasing catalase activity and activating Nrf2 pathway

Authors: Qi, X., Meng, J., Li, C., Huang, J., Lin, W.

Journal: Phytomedicine

Year: 2024

Target Discovery of Dhilirane-Type Meroterpenoids by Biosynthesis Guidance and Tailoring Enzyme Catalysis

Authors: Sun, Z., Wu, M., Zhong, B., Lin, W., Fan, A.

Journal: Journal of the American Chemical Society

Year: 2024

Targeting bacterial phospholipids and their synthesis pathways for antibiotic discovery

Authors: Song, M., Chen, S., Lin, W., Zhu, K.

Journal: Progress in Lipid Research

Year: 2024

Three-dimensional structural alignment based discovery and molecular basis of AtoB, catalyzing linear tetracyclic formation

Authors: Ma, K., Liu, J., Huang, Z., Fan, A., Lin, W.

Journal: Chemical Science

Year: 2024

New Meroterpenes from South China Sea Soft Coral Litophyton brassicum

Authors: Chen, X., Zhang, J., Yang, J., Yan, X., He, S.

Journal: Marine Drugs

Year: 2024

Dr. Tetiana | Coordination Chemistry | Best Researcher Award

Dr. Tetiana | Coordination Chemistry | Best Researcher Award

Doctorate at Institute of Chemistry, Jan Kochanowski University in Kielce |  Poland

Professional Profiles

Scopus

Orcid

🎓 Education

Dr. Tetiana Starodub graduated with honors from the prestigious National University of Vasyl Karazin in Kharkov (KhNU) in 1998. In the same year, she began her academic journey in the Department of Theoretical and Organic Chemistry at KhNU, marking the start of her commitment to advancing knowledge in the field of chemistry.

🌍 International Experience

In 2000-2001, Dr. Starodub gained invaluable international exposure by working in the laboratories of the Institute of Technology in Karlsruhe, Germany. This experience provided her with a global perspective and cutting-edge research techniques, fueling her passion for innovative chemistry.

đź§Ş Research Focus: Transition Metal Complexes and TCNQ Compounds

From 2000 to 2014, her research was centered on the synthesis of isotrithionedithiolate (dmit) transition metal complexes and the development of anion-radical salts of 7,7′,8,8′-tetracyanoquinodimethane (TCNQ ARS). Her work included studying the structures of these compounds and exploring their potential applications in modern electronics and spintronics. This period marked significant contributions to the understanding of advanced materials for emerging technologies.

🧑‍🏫 Academic Role at Jan Kochanowski University

Dr. Tetiana Starodub is currently an assistant professor at the Institute of Chemistry, Jan Kochanowski University, in Kielce, Poland. Since 2018, her scientific interests have been focused on synthetic metals, organic chemistry, and coordination chemistry, with a special emphasis on TCNQ-based compounds. Her research has explored their diverse applications in electronics, biotechnology, and medicine.

🔬 Vision for Modern Chemistry

Her research on TCNQ derivatives is driven by their promising role in constructing electrochemical sensors, energy storage devices, and medical applications. Dr. Starodub’s work continues to push the boundaries of organic and coordination chemistry, paving the way for innovations in sustainable technologies and biomedical sciences.

Publications Top Noted📝

“TCNQ and Its Derivatives as Electrode Materials in Electrochemical Investigations—Achievement and Prospects: A Review”

Authors: Starodub, T., Michalkiewicz, S.

Journal: Materials

Year: 2024

“Crystal Structure of Anion-Radical Salts of 7,7,8,8-tetracyanoquinodimethane with N-xylyl-pyridinium and N-xylyl-isoquinolinium Cations”

Authors: Starodub, T.N., Fenske, D., Fuhr, O., Yaroshenko, V.O., Stepen’, D.

Journal: Crystallography Reports

Year: 2022

“Structure, optical and electro-physical properties of tetramerized anion-radical salt (N-Xy-Qn)(TCNQ)2”

Authors: Barszcz, B., Starodub, T.N., Mizera, A., Iaroshenko, V.O., Starodub, V.A.

Journal: Spectrochimica Acta – Part A: Molecular and Biomolecular Spectroscopy

Year: 2022

“Crystal and Molecular Structure of Anion Radical Salt (N-Me-DABCO)(TCNQ)2”

Authors: Starodub, T.N., Kolosov, M.A., Fenske, D., Shishkina, S.V., Piotrowska, W.

Journal: Crystallography Reports

Year: 2022

“New radical-cation salts based on the TMTTF and TMTSF donors with iron and chromium bis(dicarbollide) complexes: Synthesis, structure, properties”

Authors: Chudak, D.M., Kazheva, O.N., Kosenko, I.D., Bregadze, V.I., Dyachenko, O.A.

Journal: Crystals

Year: 2021

Prof. Wen Jen Lin, Applied Chemistry, Best Researcher Award

Prof. Wen Jen Lin, Applied Chemistry, Best Researcher Award

Professor at National Taiwan University, Taiwan

Professional Profiles

Scopus

Orcid

🎓 Academic and Professional Background

Dr. Wen Jen Lin is a distinguished scholar in the field of pharmacy, holding a Ph.D. in Pharmaceutics from the University of Iowa, USA, and an M.S. in Pharmacokinetics from the School of Pharmacy at National Taiwan University. Dr. Lin currently serves as a Professor at the School of Pharmacy and as the Leader of the Pharmaceutical Research Group in the Drug Research Center at the College of Medicine, National Taiwan University.

🧑‍🔬 Professional Experience and Contributions

Throughout his career, Dr. Lin has made substantial contributions to both academia and the pharmaceutical industry. His roles include serving on advisory committees for Food and Drug Administration (Ministry of Health and Welfare), as a consultant for the Center for Drug Evaluation, and as an editorial board member for the Asian Journal of Pharmaceutical Sciences. He has also been a reviewer for major institutions such as the Council of Agriculture and Ministry of Science and Technology.

🏆 Honors and Awards

Dr. Lin’s expertise and dedication have been widely recognized through multiple awards, including the Senior Teacher Award (2000, 2010), the Ching-Kang Foundation Young Teacher Award (2004), and the Research Award for Academic Performance from National Taiwan University, awarded across multiple years (2007-2010, 2012-2022, 2024). Notably, he was honored with the Professor Li Jhao Ren Foundation Research Scholar Award in 2017, underlining his research impact.

👥 Professional Memberships

Dr. Lin is a permanent member of various esteemed organizations, including The Pharmaceutical Society of Taiwan, Biomaterials and Controlled Release Society of Taiwan, and Taiwan Parenteral Drug Association. His recent affiliation with The Pharmaceutical Society of Japan (2024) highlights his expanding global influence.

🔬 Areas of Research

Dr. Lin’s research specialties span nanomedicine, cancer therapy, pharmacokinetics, and biomaterials, focusing on solutions to critical clinical needs. His early work developed porous polymeric microparticles for protein release, exploring “green synthesis” methods that avoid toxic catalysts. Dr. Lin’s middle-stage research synthesized amphiphilic copolymers forming micelles for drug delivery, which he adapted for targeted therapies in liver and cancer treatment. In recent studies, he addresses challenges in glioma therapy, engineering nanoparticles capable of crossing the blood-brain barrier (BBB) for targeted delivery. Additionally, his innovative oral nanoparticle platform for acid-labile drugs presents promising advancements in gastroesophageal reflux disease treatment, improving bioavailability and sustained drug release.

Publications Top Noted📝

Zein-PEG nanoparticles modified with hyaluronic acid for paclitaxel delivery in SKOV3 ovarian cancer cells

Authors: Lai, M.-H., Lin, W.-J.
Journal: International Journal of Biological Macromolecules
Year: 2024

Improve BBB Penetration and Cytotoxicity of Palbociclib in U87-MG Glioblastoma Cells Delivered by Dual Peptide Functionalized Nanoparticles

Authors: Lo, Y.-C., Lin, W.-J.
Journal: Pharmaceutics
Year: 2023

Synergistic cytotoxicity of irinotecan combined with polysaccharide-based nanoparticles for colorectal carcinoma

Authors: Pai, F.-T., Lin, W.-J.
Journal: Biomaterials Advances
Year: 2023

Benefit of a short chain peptide as a targeting ligand of nanocarriers for a brain-driven purpose

Authors: Lo, Y.-C., Lin, W.-J.
Journal: Pharmaceutics
Year: 2021

Peptide-functionalized nanoparticles-encapsulated cyclin-dependent kinases inhibitor seliciclib in transferrin receptor overexpressed cancer cells

Authors: He, G.Z., Lin, W.-J.
Journal: Nanomaterials
Year: 2021